Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication.

Trial Profile

Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 May 2013

At a glance

  • Drugs Levocarnitine (Primary) ; Cilostazol
  • Indications Embolism and thrombosis; Intermittent claudication; Peripheral arterial disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ECLECTIC
  • Most Recent Events

    • 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Sep 2009 Planned end date changed from 1 Apr 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 20 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top